Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Prevalence of Gastric Intestinal Metaplasia in a Multi-Ethnic United States Veterans Population.

Nguyen TH, Tan MC, Liu Y, Rugge M, Thrift AP, El-Serag HB.

Clin Gastroenterol Hepatol. 2020 Mar 14. pii: S1542-3565(20)30325-6. doi: 10.1016/j.cgh.2020.03.015. [Epub ahead of print]

PMID:
32184184
2.

Outcomes Among Minority Patients With Metastatic Colorectal Cancer in a Safety-net Health Care System.

Lau-Min K, Prakash P, Jo E, Thrift AP, Hilsenbeck S, Musher BL.

Clin Colorectal Cancer. 2020 Jan 2. pii: S1533-0028(19)30446-3. doi: 10.1016/j.clcc.2019.09.002. [Epub ahead of print]

PMID:
32165040
3.

Burden of Pancreatic Cancer-From Epidemiology to Practice.

Khalaf N, El-Serag HB, Abrams HR, Thrift AP.

Clin Gastroenterol Hepatol. 2020 Mar 5. pii: S1542-3565(20)30276-7. doi: 10.1016/j.cgh.2020.02.054. [Epub ahead of print] Review.

PMID:
32147593
4.

Risk of Cirrhosis and Hepatocellular Cancer in Patients with Non-Alcoholic Fatty Liver Disease and Normal Liver Enzymes.

Natarajan Y, Kramer JR, Yu X, Li L, Thrift AP, El-Serag HB, Kanwal F.

Hepatology. 2020 Feb 5. doi: 10.1002/hep.31157. [Epub ahead of print]

PMID:
32022277
5.

Demographic and Lifestyle Risk Factors for Gastric Intestinal Metaplasia Among US Veterans.

Tan MC, Mallepally N, Liu Y, El-Serag HB, Thrift AP.

Am J Gastroenterol. 2020 Mar;115(3):381-387. doi: 10.14309/ajg.0000000000000498.

PMID:
31899705
6.

Risk Prediction Models for Barrett's Esophagus Discriminate Well and Are Generalizable in an External Validation Study.

Ireland CJ, Thrift AP, Esterman A.

Dig Dis Sci. 2020 Jan 2. doi: 10.1007/s10620-019-06018-2. [Epub ahead of print]

PMID:
31897894
7.

Sex Differences in the Risk of Barrett Esophagus Associated With the Metabolic Effects of Obesity.

Kendall BJ, Macdonald GA, Prins JB, O'Brien S, Thrift AP, Whiteman DC; Study of Digestive Health.

J Clin Gastroenterol. 2019 Dec 24. doi: 10.1097/MCG.0000000000001307. [Epub ahead of print]

PMID:
31895167
8.

Decreasing Overall and Inappropriate Proton Pump Inhibitor Use: Perspective From a Large Safety-Net Healthcare System.

Lin D, Eke C, Cai C, Thrift AP, Shukla R.

Clin Gastroenterol Hepatol. 2020 Apr;18(4):763-766.e2. doi: 10.1016/j.cgh.2019.12.015. Epub 2019 Dec 27. No abstract available.

PMID:
31887439
9.

Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.

Ayyagari S, Tan MC, Liu Y, El-Serag HB, Thrift AP.

Dig Dis Sci. 2019 Dec 4. doi: 10.1007/s10620-019-05984-x. [Epub ahead of print]

PMID:
31802383
10.

Association Between Levels of Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.

Xie SH, Fang R, Huang M, Dai J, Thrift AP, Anderson LA, Chow WH, Bernstein L, Gammon MD, Risch HA, Shaheen NJ, Reid BJ, Wu AH, Iyer PG, Liu G, Corley DA, Whiteman DC, Caldas C, Pharoah PD, Hardie LJ, Fitzgerald RC, Shen H, Vaughan TL, Lagergren J.

Clin Gastroenterol Hepatol. 2019 Nov 19. pii: S1542-3565(19)31317-5. doi: 10.1016/j.cgh.2019.11.030. [Epub ahead of print]

PMID:
31756444
11.

Shared Genetic Etiology of Obesity-Related Traits and Barrett's Esophagus/Adenocarcinoma: Insights from Genome-Wide Association Studies.

Böhmer AC, Hecker J, Schröder J, Gharahkhani P, May A, Gerges C, Anders M, Becker J, Hess T, Kreuser N, Thieme R, Noder T, Venerito M, Veits L, Schmidt T, Fuchs C, Izbicki JR, Hölscher AH, Dietrich A, Moulla Y, Lyros O, Lang H, Lorenz D, Schumacher B, Mayershofer R, Vashist Y, Ott K, Vieth M, Weismüller J, Moebus S, Knapp M, Neuhaus H, Rösch T, Ell C, Nöthen MM, Whiteman DC, Tomlinson I, Jankowski J, Fitzgerald RC, Palles C, Vaughan TL, Gockel I, Thrift AP, Fier H, Schumacher J.

Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):427-433. doi: 10.1158/1055-9965.EPI-19-0374. Epub 2019 Nov 20.

PMID:
31748258
12.

Prevalence of Helicobacter pylori Positive Non-cardia Gastric Adenocarcinoma Is Low and Decreasing in a US Population.

Nguyen TH, Mallepally N, Hammad T, Liu Y, Thrift AP, El-Serag HB, Tan MC.

Dig Dis Sci. 2019 Nov 14. doi: 10.1007/s10620-019-05955-2. [Epub ahead of print]

PMID:
31728790
13.

Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis.

Zhang X, El-Serag HB, Thrift AP.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):88-94. doi: 10.1158/1055-9965.EPI-19-1052. Epub 2019 Nov 11.

PMID:
31712271
14.

Preventable causes of cancer in Texas by race/ethnicity: Alcohol consumption.

Gudenkauf FJ, Thrift AP.

Alcohol. 2019 Oct 9;85:21-26. doi: 10.1016/j.alcohol.2019.10.001. [Epub ahead of print]

PMID:
31605725
15.

Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium.

Petrick JL, Li N, Anderson LA, Bernstein L, Corley DA, El Serag HB, Hardikar S, Liao LM, Liu G, Murray LJ, Rubenstein JH, Schneider JL, Shaheen NJ, Thrift AP, van den Brandt PA, Vaughan TL, Whiteman DC, Wu AH, Zhao WK, Gammon MD, Cook MB.

Cancer. 2019 Dec 1;125(23):4210-4223. doi: 10.1002/cncr.32444. Epub 2019 Sep 6.

PMID:
31490550
16.

Burden of Gastric Cancer.

Thrift AP, El-Serag HB.

Clin Gastroenterol Hepatol. 2020 Mar;18(3):534-542. doi: 10.1016/j.cgh.2019.07.045. Epub 2019 Jul 27. Review.

PMID:
31362118
17.

Melanoma incidence among non-Hispanic whites in all 50 United States from 2001 through 2015.

Thrift AP, Gudenkauf FJ.

J Natl Cancer Inst. 2019 Jul 25. pii: djz153. doi: 10.1093/jnci/djz153. [Epub ahead of print]

PMID:
31346623
18.

Incidence of AIDS-Related Kaposi Sarcoma in All 50 United States From 2000 to 2014.

White DL, Oluyomi A, Royse K, Dong Y, Nguyen H, Chang E, Richardson P, Jiao L, Garcia JM, Kramer JR, Thrift AP, Chiao E.

J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):387-394. doi: 10.1097/QAI.0000000000002050.

PMID:
31242141
19.

Prospective implementation of algorithmic patient selection for gastrostomy tube placement consultations: a pre- and post-intervention analysis.

Cano JJ, Thrift AP, El-Serag HB.

Clin Exp Gastroenterol. 2019 May 30;12:231-237. doi: 10.2147/CEG.S197122. eCollection 2019.

20.

Authors' reply to: Statin use and risk of liver cancer.

Tran KT, Cardwell CR, Thrift AP.

Int J Cancer. 2019 Oct 1;145(7):2009. doi: 10.1002/ijc.32506. Epub 2019 Jun 22. No abstract available.

PMID:
31199505
21.

Validation of HIV-infected cohort identification using automated clinical data in the Department of Veterans Affairs.

Kramer JR, Hartman C, White DL, Royse K, Richardson P, Thrift AP, Raychaudhury S, Desiderio R, Sanchez D, Chiao EY.

HIV Med. 2019 Sep;20(8):567-570. doi: 10.1111/hiv.12757. Epub 2019 May 26.

PMID:
31131549
22.

Statin use and risk of liver cancer: Evidence from two population-based studies.

Tran KT, McMenamin ÚC, Coleman HG, Cardwell CR, Murchie P, Iversen L, Lee AJ, Thrift AP.

Int J Cancer. 2020 Mar 1;146(5):1250-1260. doi: 10.1002/ijc.32426. Epub 2019 Jun 4.

PMID:
31112291
23.

External validation of a model to determine risk of progression of Barrett's oesophagus to neoplasia.

Kunzmann AT, Thrift AP, Johnston BT, McManus DT, Gavin AT, Turkington RC, Coleman HG.

Aliment Pharmacol Ther. 2019 May;49(10):1274-1281. doi: 10.1111/apt.15235. Epub 2019 Apr 4.

PMID:
30950101
24.

Factors associated with favorable survival outcomes for Asians with hepatocellular carcinoma: A sequential matching cohort study.

Wang Z, Gu X, Thrift AP.

PLoS One. 2019 Apr 3;14(4):e0214721. doi: 10.1371/journal.pone.0214721. eCollection 2019.

25.

Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study.

Thrift AP, Kramer JR, Hartman CM, Royse K, Richardson P, Dong Y, Raychaudhury S, Desiderio R, Sanchez D, Anandasabapathy S, White DL, Chiao EY.

J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):e65-e72. doi: 10.1097/QAI.0000000000002038.

PMID:
30939533
26.

No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.

Dong J, Gharahkhani P, Chow WH, Gammon MD, Liu G, Caldas C, Wu AH, Ye W, Onstad L, Anderson LA, Bernstein L, Pharoah PD, Risch HA, Corley DA, Fitzgerald RC; Stomach and Esophageal Cancer Study Consortium, Iyer PG, Reid BJ, Lagergren J, Shaheen NJ, Vaughan TL, MacGregor S, Love S, Palles C, Tomlinson I, Gockel I, May A, Gerges C, Anders M, Böhmer AC, Becker J, Kreuser N, Thieme R, Noder T, Venerito M, Veits L, Schmidt T, Schmidt C, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Mayershofer R, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, Jankowski J, Schumacher J, Neale RE, Whiteman DC, Thrift AP.

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2227-2235.e1. doi: 10.1016/j.cgh.2019.01.041. Epub 2019 Feb 1.

PMID:
30716477
27.

Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality.

Thrift AP, Natarajan Y, Liu Y, El-Serag HB.

Clin Gastroenterol Hepatol. 2019 Sep;17(10):2117-2125.e3. doi: 10.1016/j.cgh.2018.12.046. Epub 2019 Jan 6.

PMID:
30625400
28.

Changing Trends in Colorectal Cancers (Detected by Screening, During Screening Intervals, or Associated With Nonadherence) Identify Possible Health Care System Quality Measures.

Tau A, Bernica J, Thrift AP, El-Serag HB.

Gastroenterology. 2019 Feb;156(3):809-811. doi: 10.1053/j.gastro.2018.10.035. Epub 2018 Oct 25. No abstract available.

PMID:
30514636
29.

Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.

Hammad TA, Thrift AP, El-Serag HB, Husain NS.

Dig Dis Sci. 2019 Feb;64(2):367-372. doi: 10.1007/s10620-018-5336-5. Epub 2018 Oct 28.

30.

Ancestry and Risk of Hepatic Fibrosis and Inflammation in Patients With HCV Infection.

Thrift AP, Liu Y, Tsavachidis S, White DL, El-Serag HB.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1912-1914. doi: 10.1016/j.cgh.2018.10.024. Epub 2018 Oct 18.

PMID:
30342914
31.

Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence: Reply From Authors.

Wang Z, Thrift AP.

Am J Gastroenterol. 2018 Nov;113(11):1724-1725. doi: 10.1038/s41395-018-0356-5. Epub 2018 Oct 17. No abstract available.

PMID:
30333530
32.

Lung tissue microbial profile in lung cancer is distinct from emphysema.

Liu Y, O'Brien JL, Ajami NJ, Scheurer ME, Amirian ES, Armstrong G, Tsavachidis S, Thrift AP, Jiao L, Wong MC, Smith DP, Spitz MR, Bondy ML, Petrosino JF, Kheradmand F.

Am J Cancer Res. 2018 Sep 1;8(9):1775-1787. eCollection 2018.

33.

Editorial: less acid, less cancer? Is this the question? Authors' reply.

Tan MC, Thrift AP.

Aliment Pharmacol Ther. 2018 Oct;48(8):878-879. doi: 10.1111/apt.14971. No abstract available.

34.

Time to Tailor Surveillance Intervals of Nondysplastic Barrett's Esophagus According to Segment Length and Persistence Over Multiple Endoscopies.

Thrift AP, Kunzmann AT.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):832-834. doi: 10.1016/j.cgh.2018.09.025. Epub 2018 Sep 26. No abstract available.

PMID:
30267865
35.

Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors.

Kunzmann AT, Cañadas Garre M, Thrift AP, McMenamin ÚC, Johnston BT, Cardwell CR, Anderson LA, Spence AD, Lagergren J, Xie SH, Smyth LJ, McKnight AJ, Coleman HG.

Gastroenterology. 2019 Jan;156(1):43-45. doi: 10.1053/j.gastro.2018.09.038. Epub 2018 Sep 19.

PMID:
30243622
36.

Diagnostics for Pleiotropy in Mendelian Randomization Studies: Global and Individual Tests for Direct Effects.

Dai JY, Peters U, Wang X, Kocarnik J, Chang-Claude J, Slattery ML, Chan A, Lemire M, Berndt SI, Casey G, Song M, Jenkins MA, Brenner H, Thrift AP, White E, Hsu L.

Am J Epidemiol. 2018 Dec 1;187(12):2672-2680. doi: 10.1093/aje/kwy177.

37.

Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.

Kanwal F, Kramer JR, Mapakshi S, Natarajan Y, Chayanupatkul M, Richardson PA, Li L, Desiderio R, Thrift AP, Asch SM, Chu J, El-Serag HB.

Gastroenterology. 2018 Dec;155(6):1828-1837.e2. doi: 10.1053/j.gastro.2018.08.024. Epub 2018 Aug 23.

38.

Prior Diagnosis of Barrett's Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival.

Wenker TN, Tan MC, Liu Y, El-Serag HB, Thrift AP.

Dig Dis Sci. 2018 Nov;63(11):3112-3119. doi: 10.1007/s10620-018-5241-y. Epub 2018 Aug 14.

39.

Underuse of Surgery Accounts for Racial Disparities in Esophageal Cancer Survival Times: A Matched Cohort Study.

Dong J, Gu X, El-Serag HB, Thrift AP.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):657-665.e13. doi: 10.1016/j.cgh.2018.07.018. Epub 2018 Jul 20.

PMID:
30036643
40.

Long-term follow up of patients with obscure gastrointestinal bleeding examined with video capsule endoscopy.

Sealock RJ, Thrift AP, El-Serag HB, Sellin J.

Medicine (Baltimore). 2018 Jul;97(29):e11429. doi: 10.1097/MD.0000000000011429.

41.

Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.

Tan MC, El-Serag HB, Yu X, Thrift AP.

Aliment Pharmacol Ther. 2018 Aug;48(4):469-477. doi: 10.1111/apt.14895. Epub 2018 Jun 29.

42.

The Association Between Statin Use After Diagnosis and Mortality Risk in Patients With Esophageal Cancer: A Retrospective Cohort Study of United States Veterans.

Nguyen T, Khan A, Liu Y, El-Serag HB, Thrift AP.

Am J Gastroenterol. 2018 Sep;113(9):1310. doi: 10.1038/s41395-018-0169-6. Epub 2018 Jun 27.

PMID:
29946180
43.

Factors Associated With Recurrence of Barrett's Esophagus After Radiofrequency Ablation.

Tan MC, Kanthasamy KA, Yeh AG, Kil D, Pompeii L, Yu X, El-Serag HB, Thrift AP.

Clin Gastroenterol Hepatol. 2019 Jan;17(1):65-72.e5. doi: 10.1016/j.cgh.2018.05.042. Epub 2018 Jun 11.

PMID:
29902646
44.

Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.

Wang Z, Shaheen NJ, Whiteman DC, Anderson LA, Vaughan TL, Corley DA, El-Serag HB, Rubenstein JH, Thrift AP.

Am J Gastroenterol. 2018 Aug;113(8):1148-1155. doi: 10.1038/s41395-018-0070-3. Epub 2018 Jun 8.

PMID:
29880962
45.

Are Non-HIV Malignancies Increased in the HIV-Infected Population?

Thrift AP, Chiao EY.

Curr Infect Dis Rep. 2018 May 26;20(8):22. doi: 10.1007/s11908-018-0626-9. Review.

PMID:
29804238
46.

Lorenz Curves and Gini Coefficient Analyses Indicate Inefficiencies in Esophageal Adenocarcinoma Screening.

Hur C, Zhan T, Thrift AP, Vaughan TL, Feuer EJ.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):560-562.e2. doi: 10.1016/j.cgh.2018.05.002. Epub 2018 May 9.

47.

Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies.

Tran KT, McMenamin ÚC, Hicks B, Murchie P, Thrift AP, Coleman HG, Iversen L, Johnston BT, Lee AJ, Cardwell CR.

Aliment Pharmacol Ther. 2018 Jul;48(1):55-64. doi: 10.1111/apt.14796. Epub 2018 May 9.

48.

Incidence of gastric cancer in the USA during 1999 to 2013: a 50-state analysis.

Wang Z, Graham DY, Khan A, Balakrishnan M, Abrams HR, El-Serag HB, Thrift AP.

Int J Epidemiol. 2018 Jun 1;47(3):966-975. doi: 10.1093/ije/dyy055.

49.

Barrett's Esophagus and Esophageal Adenocarcinoma: How Common Are They Really?

Thrift AP.

Dig Dis Sci. 2018 Aug;63(8):1988-1996. doi: 10.1007/s10620-018-5068-6. Review.

PMID:
29671158
50.

Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.

Cotton CC, Haidry R, Thrift AP, Lovat L, Shaheen NJ.

Gastroenterology. 2018 Aug;155(2):316-326.e6. doi: 10.1053/j.gastro.2018.04.011. Epub 2018 Apr 13.

Supplemental Content

Loading ...
Support Center